Benitec Biopharma Limited(BNTC)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BNTC Benitec Biopharma Limited

休市中 08-21 16:00:00 EDT

13.48

+0.47

+3.61%

盘后13.48

+0.000.00%

19:30 EDT

最高13.98	最低13.03	成交量16.01万
今开13.14	昨收13.01	日振幅7.30%
总市值4.62亿	流通市值2.42亿	总股本3,425万
成交额218.56万	换手率0.89%	流通股本1,793万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"BNTC","market":"US","secType":"STK","nameCN":"Benitec Biopharma Limited","latestPrice":13.48,"timestamp":1787342400000,"preClose":13.01,"halted":0,"volume":160139,"hourTrading":{"tag":"盘后","latestPrice":13.48,"preClose":13.48,"latestTime":"19:30 EDT","volume":8,"amount":107.84,"timestamp":1787355006358,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.036126056879323645,"floatShares":17925000,"shares":34254907,"eps":-0.933773,"marketStatus":"休市中","change":0.47,"latestTime":"08-21 16:00:00 EDT","open":13.14,"high":13.98,"low":13.03,"amount":2185588.602008,"amplitude":0.073021,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.933773,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":7,"adr":1,"adrRate":200,"listingDate":1439870400000,"exchange":"NASDAQ","adjPreClose":13.01,"postHourTrading":{"tag":"盘后","latestPrice":13.48,"preClose":13.48,"latestTime":"19:30 EDT","volume":8,"amount":107.84,"timestamp":1787355006358,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.7801094705500221,"impliedVol":1.2065,"impliedVolPercentile":0.9283},"requestUrl":"/m/hq/s/BNTC","defaultTab":"news","newsList":[{"id":"1136572855","title":"诺华Itvisma®获欧盟批准用于脊髓性肌萎缩症","url":"https://stock-news.laohu8.com/highlight/detail?id=1136572855","media":"投资观察","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1136572855?lang=zh_cn&edition=full","pubTime":"2026-07-07 16:45","pubTimestamp":1783413943,"startTime":"0","endTime":"0","summary":"诺华集团宣布，其用于治疗脊髓性肌萎缩症（SMA）的一次性固定剂量基因疗法Itvisma®已获得欧盟委员会的上市批准。\n根据诺华发布的信息，Itvisma是一种基因替代疗法。此次批准意味着，该疗法现已在欧盟范围内适用于所有年龄段的SMA患者群体。诺华指出，其STEER和STRENGTH研究数据显示，该疗法能为SMA患者带来具有临床意义的获益。\nItvisma由此成为欧盟首个获批用于广泛SMA人群的基因替代疗法。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BNTC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103323800","title":"诺华Itvisma®获欧盟委员会批准用于脊髓性肌萎缩症治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=1103323800","media":"投资观察","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1103323800?lang=zh_cn&edition=full","pubTime":"2026-07-02 13:14","pubTimestamp":1782969282,"startTime":"0","endTime":"0","summary":"诺华公司宣布，其用于治疗脊髓性肌萎缩症（SMA）的基因疗法Itvisma®已获得欧盟委员会批准。该疗法是一种一次性、固定剂量的基因治疗药物。\n此次批准意味着，在欧盟范围内，SMA患者无论年龄大小，现在都有资格接受基因替代疗法。关键性的STEER和STRENGTH研究数据显示，Itvisma为SMA患者带来了具有临床意义的显著获益。\n由此，Itvisma成为欧盟首个获准用于广泛SMA人群的基因替代疗法，标志着该疾病治疗领域的一个重要里程碑。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BNTC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184463806","title":"Benitec Biopharma有望年中与FDA接洽，敲定BB-301关键性研究设计方案","url":"https://stock-news.laohu8.com/highlight/detail?id=1184463806","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1184463806?lang=zh_cn&edition=full","pubTime":"2026-05-14 20:14","pubTimestamp":1778760868,"startTime":"0","endTime":"0","summary":"Benitec Biopharma Limited正稳步推进其核心项目，计划于今年年中与美国食品药品监督管理局（FDA）进行正式接洽。此次会议的核心目标，是就其实验性基因疗法BB-301的关键性（pivotal）研究设计方案达成最终共识并予以正式确定。这一步骤对于该疗法后续的临床开发路径至关重要，标志着项目向下一阶段实质性迈进。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BNTC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139615956","title":"Benitec Biopharma将在2026年美国基因与细胞治疗学会年会公布高剂量BB-301中期1B/2a期临床研究结果及低剂量组持续改善数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1139615956","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1139615956?lang=zh_cn&edition=full","pubTime":"2026-04-28 19:02","pubTimestamp":1777374140,"startTime":"0","endTime":"0","summary":"Benitec Biopharma Limited（以下简称Benitec）宣布，其将在2026年美国基因与细胞治疗学会（ASGCT）年会上，以口头报告形式公布两项关键临床研究进展。报告将重点展示高剂量BB-301的1B/2a期临床试验的中期分析结果，同时披露低剂量BB-301组别持续表现出的持久性改善数据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BNTC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618950569","title":"Benitec Biopharma Inc.盘中异动 股价大涨5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618950569","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2618950569?lang=zh_cn&edition=full","pubTime":"2026-03-10 21:39","pubTimestamp":1773149997,"startTime":"0","endTime":"0","summary":"北京时间2026年03月10日21时39分，Benitec Biopharma Inc.股票出现波动，股价大幅拉升5.18%。Benitec Biopharma Inc.股票所在的生物技术行业中，整体涨幅为1.40%。其相关个股中，Mink Therapeutics, Inc.、Longeveron Inc.、Biorestorative Therapies, Inc.涨幅较大，Biorestorative Therapies, Inc.、Mink Therapeutics, Inc.、Scisparc Ltd.较为活跃，换手率分别为552.79%、223.76%、145.29%，振幅较大的相关个股有Acurx Pharmaceuticals, Inc.、Klotho Neurosciences, Inc.、Tenax Therapeutics, Inc.，振幅分别为24.04%、18.28%、16.52%。Benitec Biopharma Inc.公司简介：Benitec Biopharma Inc 是一家临床阶段的生物技术公司，专注于新型基因药物的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260310213957a6b5a114&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260310213957a6b5a114&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BNTC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139009781","title":"Benitec Biopharma公布高剂量BB-301积极Ib/IIa期中期结果，低剂量治疗在2026年MDA会议上展现持续持久改善","url":"https://stock-news.laohu8.com/highlight/detail?id=1139009781","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1139009781?lang=zh_cn&edition=full","pubTime":"2026-03-09 19:02","pubTimestamp":1773054179,"startTime":"0","endTime":"0","summary":"在2026年肌肉萎缩症协会临床与科学会议上，Benitec Biopharma Limited公布了其候选药物BB-301的最新临床试验数据。结果显示，高剂量BB-301在Ib/IIa期研究中取得了积极的中期成果，同时，低剂量治疗方案继续展现出持久的改善效果。这一进展为该药物治疗肌肉萎缩性疾病的潜力提供了进一步支持。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BNTC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518206419","title":"Benitec Biopharma Inc.盘中异动 下午盘急速跳水5.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518206419","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518206419?lang=zh_cn&edition=full","pubTime":"2025-03-11 02:03","pubTimestamp":1741629808,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日02时03分，Benitec Biopharma Inc.股票出现波动，股价大幅下挫5.77%。Benitec Biopharma Inc.股票所在的生物技术行业中，整体涨幅为0.78%。其相关个股中，Aeon Biopharma, Inc.、Mineralys Therapeutics, Inc.、Checkpoint Therapeutics, Inc.涨幅较大，Aeon Biopharma, Inc.、Biodexa Pharmaceuticals Plc、Scisparc Ltd.较为活跃，换手率分别为5706.90%、3830.19%、994.05%，振幅较大的相关个股有Aeon Biopharma, Inc.、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Biodexa Pharmaceuticals Plc，振幅分别为90.44%、88.14%、58.34%。Benitec Biopharma Inc.公司简介：Benitec Biopharma Inc 是一家临床阶段的生物技术公司，专注于新型基因药物的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031102032896406c0a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031102032896406c0a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BNTC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517192752","title":"Benitec Biopharma Inc.盘中异动 股价大涨5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517192752","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517192752?lang=zh_cn&edition=full","pubTime":"2025-03-07 03:51","pubTimestamp":1741290676,"startTime":"0","endTime":"0","summary":"北京时间2025年03月07日03时51分，Benitec Biopharma Inc.股票出现波动，股价快速拉升5.41%。截至发稿，该股报12.86美元/股，成交量3.2456万股，换手率0.14%，振幅8.22%。Benitec Biopharma Inc.股票所在的生物技术行业中，整体跌幅为0.89%。Benitec Biopharma Inc.公司简介：Benitec Biopharma Inc 是一家临床阶段的生物技术公司，专注于新型基因药物的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307035117a262dbf7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307035117a262dbf7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BNTC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516672701","title":"Benitec Biopharma Inc.盘中异动 早盘股价大跌7.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516672701","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516672701?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:34","pubTimestamp":1741098879,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时34分，Benitec Biopharma Inc.股票出现异动，股价快速下跌7.33%。Benitec Biopharma Inc.股票所在的生物技术行业中，整体跌幅为0.08%。其相关个股中，Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Protagenic Therapeutics, Inc.、Exicure, Inc.涨幅较大，Aeon Biopharma, Inc.、Windtree Therapeutics, Inc.、Protagenic Therapeutics, Inc.较为活跃，换手率分别为1073.03%、1067.22%、422.18%，振幅较大的相关个股有Celularity Inc C/Wts 16/07/2026 、Adma Biologics Inc、Ibio, Inc.，振幅分别为23.30%、12.57%、11.23%。Benitec Biopharma Inc.公司简介：Benitec Biopharma Inc 是一家临床阶段的生物技术公司，专注于新型基因药物的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503042234399639457b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503042234399639457b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BNTC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516963495","title":"Benitec Biopharma Inc.盘中异动 股价大跌6.84%报11.84美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516963495","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516963495?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:33","pubTimestamp":1741012397,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时33分，Benitec Biopharma Inc.股票出现波动，股价大幅下挫6.84%。截至发稿，该股报11.84美元/股，成交量3421股，换手率0.01%，振幅1.99%。Benitec Biopharma Inc.股票所在的生物技术行业中，整体涨幅为0.21%。Benitec Biopharma Inc.公司简介：Benitec Biopharma Inc 是一家临床阶段的生物技术公司，专注于新型基因药物的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223317a25d4050&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223317a25d4050&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BNTC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516308850","title":"Benitec Biopharma Inc.盘中异动 急速上涨5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516308850","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516308850?lang=zh_cn&edition=full","pubTime":"2025-03-01 02:30","pubTimestamp":1740767426,"startTime":"0","endTime":"0","summary":"北京时间2025年03月01日02时30分，Benitec Biopharma Inc.股票出现波动，股价大幅拉升5.17%。Benitec Biopharma Inc.股票所在的生物技术行业中，整体涨幅为0.13%。其相关个股中，Enveric Biosciences, Inc.、Camp4 Therapeutics Corporation、Bioxcel Therapeutics, Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Enveric Biosciences, Inc.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为3198.89%、536.20%、379.18%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 ，振幅分别为57.80%、49.90%、48.19%。Benitec Biopharma Inc.公司简介：Benitec Biopharma Inc 是一家临床阶段的生物技术公司，专注于新型基因药物的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301023026abe120f7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301023026abe120f7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BNTC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514384784","title":"Benitec Biopharma Inc.盘中异动 急速拉升5.63%报11.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514384784","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514384784?lang=zh_cn&edition=full","pubTime":"2025-02-27 23:58","pubTimestamp":1740671894,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日23时58分，Benitec Biopharma Inc.股票出现异动，股价快速上涨5.63%。截至发稿，该股报11.37美元/股，成交量2622股，换手率0.01%，振幅2.97%。Benitec Biopharma Inc.股票所在的生物技术行业中，整体涨幅为0.71%。Benitec Biopharma Inc.公司简介：Benitec Biopharma Inc 是一家临床阶段的生物技术公司，专注于新型基因药物的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227235815abdf844e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227235815abdf844e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BNTC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514702807","title":"Benitec Biopharma Inc.盘中异动 股价大跌5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514702807","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514702807?lang=zh_cn&edition=full","pubTime":"2025-02-25 03:30","pubTimestamp":1740425426,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日03时30分，Benitec Biopharma Inc.股票出现异动，股价快速下挫5.31%。截至发稿，该股报10.70美元/股，成交量4.0375万股，换手率0.17%，振幅6.55%。Benitec Biopharma Inc.股票所在的生物技术行业中，整体跌幅为0.36%。Benitec Biopharma Inc.公司简介：Benitec Biopharma Inc 是一家临床阶段的生物技术公司，专注于新型基因药物的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225033026abdb4d57&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225033026abdb4d57&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BNTC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511699740","title":"Benitec Biopharma Inc.盘中异动 早盘急速拉升5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511699740","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511699740?lang=zh_cn&edition=full","pubTime":"2025-02-14 22:32","pubTimestamp":1739543534,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日22时32分，Benitec Biopharma Inc.股票出现波动，股价大幅拉升5.15%。Benitec Biopharma Inc.股票所在的生物技术行业中，整体涨幅为0.24%。其相关个股中，Moleculin Biotech, Inc.、Virpax Pharmaceuticals, Inc.、Cns Pharmaceuticals, Inc.涨幅较大，Moleculin Biotech, Inc.、Virpax Pharmaceuticals, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为1010.89%、361.45%、330.43%，振幅较大的相关个股有Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Theratechnologies Inc.、Virpax Pharmaceuticals, Inc.，振幅分别为20.20%、18.33%、15.20%。Benitec Biopharma Inc.公司简介：Benitec Biopharma Inc 是一家临床阶段的生物技术公司，专注于新型基因药物的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214223214a2460100&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214223214a2460100&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BNTC","BK4007","VRPX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119209714","title":"Benitec Biopharma 2025年第二季度GAAP每股收益$(0.33)优于预期$(0.87)","url":"https://stock-news.laohu8.com/highlight/detail?id=1119209714","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1119209714?lang=zh_cn&edition=full","pubTime":"2025-02-14 21:12","pubTimestamp":1739538761,"startTime":"0","endTime":"0","summary":"Benitec Biopharma 2025年第二季度GAAP每股收益 $(0.33) 优于预期 $(0.87)以上内容来自Benzinga Earnings专栏，原文如下：Benitec Biopharma Q2 2025 GAAP EPS $(0.33) Beats $(0.87) Estimate","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Benitec Biopharma 2025年第二季度GAAP每股收益$(0.33)优于预期$(0.87)","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BNTC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511783522","title":"Benitec Biopharma Inc.盘中异动 大幅拉升8.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511783522","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511783522?lang=zh_cn&edition=full","pubTime":"2025-02-14 00:18","pubTimestamp":1739463525,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日00时18分，Benitec Biopharma Inc.股票出现异动，股价大幅上涨8.33%。截至发稿，该股报11.05美元/股，成交量1.1856万股，换手率0.05%，振幅3.43%。Benitec Biopharma Inc.股票所在的生物技术行业中，整体涨幅为0.94%。Benitec Biopharma Inc.公司简介：Benitec Biopharma Inc 是一家临床阶段的生物技术公司，专注于新型基因药物的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214001845a244c271&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214001845a244c271&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BNTC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510896918","title":"Benitec Biopharma Inc.盘中异动 急速拉升6.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510896918","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510896918?lang=zh_cn&edition=full","pubTime":"2025-02-11 02:27","pubTimestamp":1739212073,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日02时27分，Benitec Biopharma Inc.股票出现波动，股价急速拉升6.41%。Benitec Biopharma Inc.股票所在的生物技术行业中，整体跌幅为0.29%。其相关个股中，60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Biodexa Pharmaceuticals Plc、Dominari Holdings Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Nls Pharmaceutics Ltd.、Ocean Biomedical, Inc.较为活跃，换手率分别为3061.98%、1637.96%、1332.25%，振幅较大的相关个股有Immatics N V C/Wts 01/07/2025 、Abpro Holdings Inc C/Wts 12/11/2029 、Biodexa Pharmaceuticals Plc，振幅分别为99.86%、87.80%、87.71%。Benitec Biopharma Inc.公司简介：Benitec Biopharma Inc 是一家临床阶段的生物技术公司，专注于新型基因药物的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502110227539880a678&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502110227539880a678&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BNTC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508214779","title":"Benitec Biopharma Inc.盘中异动 早盘急速上涨5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508214779","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508214779?lang=zh_cn&edition=full","pubTime":"2025-02-03 23:44","pubTimestamp":1738597499,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日23时44分，Benitec Biopharma Inc.股票出现波动，股价急速拉升5.31%。Benitec Biopharma Inc.股票所在的生物技术行业中，整体跌幅为0.49%。其相关个股中，Hcw Biologics Inc.、Gh Research Plc、Invivyd, Inc.涨幅较大，Hcw Biologics Inc.、Briacell Therapeutics Corp.、Cyclerion Therapeutics, Inc.较为活跃，换手率分别为553.49%、423.17%、350.89%，振幅较大的相关个股有Hcw Biologics Inc.、Invivyd, Inc.、Briacell Therapeutics Corp.，振幅分别为158.16%、75.23%、53.59%。Benitec Biopharma Inc.公司简介：Benitec Biopharma Inc 是一家临床阶段的生物技术公司，专注于新型基因药物的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203234459961707e4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203234459961707e4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BNTC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508699254","title":"Benitec Biopharma Inc.盘中异动 股价大涨5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508699254","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508699254?lang=zh_cn&edition=full","pubTime":"2025-02-01 04:25","pubTimestamp":1738355138,"startTime":"0","endTime":"0","summary":"北京时间2025年02月01日04时25分，Benitec Biopharma Inc.股票出现异动，股价快速上涨5.22%。截至发稿，该股报11.48美元/股，成交量1.693万股，换手率0.07%，振幅5.59%。Benitec Biopharma Inc.股票所在的生物技术行业中，整体涨幅为0.60%。Benitec Biopharma Inc.公司简介：Benitec Biopharma Inc 是一家临床阶段的生物技术公司，专注于新型基因药物的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020104253896151331&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020104253896151331&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BNTC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2504195241","title":"Benitec Biopharma Inc.盘中异动 急速下挫5.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2504195241","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2504195241?lang=zh_cn&edition=full","pubTime":"2025-01-18 04:31","pubTimestamp":1737145914,"startTime":"0","endTime":"0","summary":"北京时间2025年01月18日04时31分，Benitec Biopharma Inc.股票出现波动，股价快速下挫5.52%。Benitec Biopharma Inc.股票所在的生物技术行业中，整体涨幅为0.28%。其相关个股中，Channel Therapeutics Corporation、Immatics N V C/Wts 01/07/2025 、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 涨幅较大，Aditxt, Inc.、Channel Therapeutics Corporation、Scorpius Holdings, Inc.较为活跃，换手率分别为246.49%、180.39%、103.55%，振幅较大的相关个股有Channel Therapeutics Corporation、Immatics N V C/Wts 01/07/2025 、Scorpius Holdings, Inc.，振幅分别为150.00%、117.68%、68.41%。Benitec Biopharma Inc.公司简介：Benitec Biopharma Inc 是一家临床阶段的生物技术公司，专注于新型基因药物的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250118043154abaefdab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250118043154abaefdab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BNTC"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.benitec.com","stockEarnings":[{"period":"1week","weight":0.0732},{"period":"1month","weight":0.1783},{"period":"3month","weight":0.2004},{"period":"6month","weight":0.2669},{"period":"1year","weight":0.0614},{"period":"ytd","weight":0.0007}],"compareEarnings":[{"period":"1week","weight":-0.0137},{"period":"1month","weight":0.0245},{"period":"3month","weight":0.0269},{"period":"6month","weight":0.1107},{"period":"1year","weight":0.2048},{"period":"ytd","weight":0.1229}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Benitec Biopharma Inc.于2019年11月22日在特拉华州注册成立，总部位于加利福尼亚州海沃德，其起源可追溯至1995年在澳大利亚成立的Benitec Limited，之后于2020年4月15日完成了对美国的重新注册。是一家从事创新基因药物开发的临床阶段生物技术公司。该公司的专有平台DNA导向的RNA干扰（ddRNAi），将RNA干扰与基因治疗相结合，以实现疾病相关基因的长期沉默和替代基因的传递，构成其“沉默和替代”战略的基础。Benitec正在开发BB-301，这是一种用于治疗眼咽肌营养不良症的候选基因疗法，该药物已在美国和欧盟获得孤儿药指定。通过专注于基因医学和专门的治疗方法，该公司在生物技术领域拥有公认的地位。","yearOnYearQuotes":[{"month":1,"riseRate":0.363636,"avgChangeRate":0.034036},{"month":2,"riseRate":0.545455,"avgChangeRate":0.090462},{"month":3,"riseRate":0.727273,"avgChangeRate":0.04636},{"month":4,"riseRate":0.454545,"avgChangeRate":0.035631},{"month":5,"riseRate":0.363636,"avgChangeRate":-0.04959},{"month":6,"riseRate":0.272727,"avgChangeRate":-0.105281},{"month":7,"riseRate":0.454545,"avgChangeRate":0.044486},{"month":8,"riseRate":0.454545,"avgChangeRate":0.009514},{"month":9,"riseRate":0.272727,"avgChangeRate":-0.108578},{"month":10,"riseRate":0.636364,"avgChangeRate":-0.026473},{"month":11,"riseRate":0.272727,"avgChangeRate":-0.075117},{"month":12,"riseRate":0.545455,"avgChangeRate":-0.032403}],"exchange":"NASDAQ","name":"Benitec Biopharma Limited","nameEN":"Benitec Biopharma"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Benitec Biopharma Limited(BNTC)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Benitec Biopharma Limited(BNTC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Benitec Biopharma Limited,BNTC,Benitec Biopharma Limited股票,Benitec Biopharma Limited股票老虎,Benitec Biopharma Limited股票老虎国际,Benitec Biopharma Limited行情,Benitec Biopharma Limited股票行情,Benitec Biopharma Limited股价,Benitec Biopharma Limited股市,Benitec Biopharma Limited股票价格,Benitec Biopharma Limited股票交易,Benitec Biopharma Limited股票购买,Benitec Biopharma Limited股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Benitec Biopharma Limited(BNTC)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Benitec Biopharma Limited(BNTC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}